XTLB
XTL Biopharmaceuticals
XTLB
XTLB
5 hedge funds and large institutions have $1.1M invested in XTL Biopharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$82K |
Top Sellers
| 1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$15K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $469K | 198,889 | – | – |
|
|
NC
2
Noked Capital
Tel Aviv,
Israel
| $469K | 198,889 | – | – |
|
|
3
Morgan Stanley
New York
| $82K | 34,732 | +1,600 | +5% |
|
4
Invesco
Atlanta,
Georgia
| $61K | 25,961 | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $15K | 6,328 | -343 | -5% |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -1,300 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|